Fusion protein-mediated costimulation in engineered T cells: from intrinsic signaling to tumor microenvironment rewiring - Top-Institutions - MDSpire

Fusion protein-mediated costimulation in engineered T cells: from intrinsic signaling to tumor microenvironment rewiring

By
Ryma Toumi
Simonne J. Guenette
Shannon K. Oda
June 17, 2026
0 min

Frontiers In Immunology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

University of Pennsylvania – Abramson Cancer Center

Philadelphia, Pennsylvania
Key Differentiators
- Oncology
- Cellular Immunotherapy
#2

Memorial Sloan Kettering Cancer Center

New York, New York
Key Differentiators
- Oncology
- Cancer Research
#3

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Oncology
- Cancer Treatment
#4

The Ohio State University Comprehensive Cancer Center

Columbus, Ohio
Key Differentiators
- Oncology
- Cancer Research
#5

Dana-Farber Cancer Institute

Boston, Massachusetts
Key Differentiators
- Oncology
- Cancer Research

Original Source(s)

Frontiers In Immunology

Fusion protein-mediated costimulation in engineered T cells: from intrinsic signaling to tumor microenvironment rewiring

by Ryma Toumi, Simonne J. Guenette, Shannon K. Oda
June 17, 2026

Related Content

Npj Digital Medicine

Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence

Frontiers In Immunology

Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report

by Yanling Yuan, Wanming He, Lihua Tong, Yu Yang, Wen Yang
June 17, 2026

Frontiers In Oncology

Artificial intelligence–enabled liquid biopsy in cancer: a systematic review and meta- analysis of diagnostic performance and biological implications